Abstract
After historically situating NBIC Convergence in the context of earlier bioethical debate on genetics, ten questions are raised in areas related to the ethics of Convergence, indicating where future research is needed.
ACKNOWLEDGEMENT
This essay is based on work supported by the National Science Foundation award EEC–0646332–Complexity, Systems and Control in Nanobiotechnology: Developing a framework for understanding and managing uncertainty associated with Radically Disruptive Technology. The views expressed in this essay do not necessarily represent those of the National Science Foundation.